News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunomedics, Inc. (IMMU) Announces Results From 3 Clinical Trials Will be Presented at the 59th Annual Meeting of the Society of Nuclear Medicine


6/5/2012 9:48:39 AM

MORRIS PLAINS, N.J., June 5, 2012 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that 7 presentations, of which 6 are oral presentations, will be given at the 59th Annual Meeting of the Society of Nuclear Medicine (SNM), scheduled for June 9 – 13, 2012, in Miami Beach, FL.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES